image credit: Unsplash

FDA reports first drug shortage due to coronavirus impact

February 28, 2020

Virus containment measures imposed by the Chinese government have resulted in shutdowns or partial closures at manufacturing plants in Wuhan, the province in which the new coronavirus emerged, as well as other nearby areas.

For the drug industry, sustained reductions in Chinese production could quickly become a problem. The country accounts for a good deal of the active pharmaceutical ingredients contained in many common drugs, as well as the starting chemicals used to produced those ingredients elsewhere.

Read More on Biopharma Dive